Quarterly report pursuant to Section 13 or 15(d)

Note 2 - Revenue Recognition (Details Textual)

v3.20.2
Note 2 - Revenue Recognition (Details Textual) - USD ($)
$ in Millions
3 Months Ended
Sep. 30, 2020
Jun. 30, 2020
Proceeds from Laboratory Services Reimbursed by Medicare $ 0.5  
Contract with Customer, Liability, Total 13.4 $ 14.2
Contract with Customer, Liability, Revenue Recognized $ 4.8